BIOTRONIK Launches Solia CSP S, Aiming to Simplify Conduction System Pacing Procedures World’s First Cardiac Pacing Lead to Combine a Fixed Screw Design with Stylet-Driven Implantation — Engineered Exclusively for Conduction System Pacing
BIOTRONIK, a global leader in medical technology, today announced the market release of Solia CSP S, the latest innovation in its growing portfolio of Conduction System Pacing (CSP) solutions. Solia CSP S is the first and only pacing lead worldwide that combines a fixed screw design with a stylet-driven implantation approach1, offering physicians a new solution designed to simplify CSP procedures while enhancing control and precision.
The first global commercial implants were successfully performed by Dr. Óscar Cano at the University and Polytechnic La Fe Hospital of Valencia, Spain. “In my experience, the stylet-driven Solia CSP S together with the Selectra 3D catheter enabled good alignment with the septal wall and it was easy to penetrate the septum,” said Dr. Cano. “The procedures went very fast, and we had only minimal use of fluoroscopy.”
Solia CSP S uniquely combines the advantages of both fixed screw and stylet-driven designs, so physicians no longer have to compromise. The fixed screw design reduces preparation time while the stylet enables high steerability and continuous electrical measurements2.
Solia CSP S introduces several innovations that support a more efficient and controlled CSP procedure2. The newly developed screw is designed to enable smoother and more precise septal tissue penetration, helping reduce the number of lead rotations2. The lead’s simplified handling minimizes preparation steps and allows for single operator use. Its optimized distal end is also designed to further strengthen durability and enhance steerability, giving physicians better control during implantation2. The result is a dedicated CSP lead that is designed to offer greater control, efficiency, and confidence during implantation.
“The launch of Solia CSP S represents a step forward in making CSP procedures more accessible and efficient,” said Andreas Hecker, President CRM/EP at BIOTRONIK. “It is part of our ongoing commitment to physiologic pacing and providing physicians with tools that streamline implantation for better patient outcomes.”
Conduction System Pacing currently emerges as a new standard of care within cardiac device therapy. Manufacturers are asked to develop dedicated tools, to meet this growing demand, as healthcare providers rely on solutions that support faster procedures across diverse patient populations. “The challenge in cardiac rhythm management today, is to treat more patients while maintaining the highest standards of care,” added Dr. Joaquín Osca Asensi, Head of the Arrhythmia Unit at La Fe Hospital of Valencia, Spain. “Tools like BIOTRONIK’s CSP solution help us deliver physiologic pacing while keeping workflows lean and manageable.”
-END-
References
1. BIOTRONIK Solia CSP S technical manual; Medtronic SelectSecure 3830 technical manual; Boston Scientific INGEVITY+ physician's lead manual; Abbott UltiPace user’s manual.
2. BIO|MASTER.CSP Interim Clinical Analysis Report. Data on file.
Find more information about Solia CSP S on our product page.
About BIOTRONIK
For over 60 years, BIOTRONIK has stood at the forefront of medical technology, pioneering breakthrough innovations that are transforming the lives of millions affected by heart disease and chronic pain. Rooted in a deep purpose to seamlessly harmonize technology with the human body, we engineer trusted, life-changing therapies through our advanced active implants in Cardiac Rhythm Management, Monitoring, and Neuromodulation, while providing cutting-edge solutions in Electrophysiology. From creating Germany’s first pacemaker in 1963 to breaking new ground in digital technologies and Conduction System Pacing today, BIOTRONIK is continuously raising the bar for quality, performance, and innovation. Headquartered in Berlin, our global reach spans over 100 countries across the Americas, EMEA, and Asia—bringing bold, future-ready solutions that are shaping the next generation of medical technology.
Media Contact
BIOTRONIK Press Office: press@biotronik.com
